Lungtech, a phase II EORTC trial of SBRT for centrally located lung tumours – a clinical physics perspective

BACKGROUND: The EORTC has launched a phase II trial to assess safety and efficacy of SBRT for centrally located NSCLC: The EORTC 22113-08113—Lungtech trial. Due to neighbouring critical structures, these tumours remain challenging to treat. To guarantee accordance to protocol and treatment safety, a...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Radiat Oncol
Main Authors: Lambrecht, Marie, Melidis, Christos, Sonke, Jan-Jakob, Adebahr, Sonja, Boellaard, Ronald, Verheij, Marcel, Guckenberger, Matthias, Nestle, Ursula, Hurkmans, Coen
Formato: Artigo
Idioma:Inglês
Publicado em: BioMed Central 2016
Assuntos:
Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4721147/
https://ncbi.nlm.nih.gov/pubmed/26791788
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13014-015-0567-5
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados